Alphabetical list:
A B C D E F G H I J K L M N O P R S T U V W X Y Q Z 1 2 3 4 5 6 7 8 9
News: December 5, 2009
Half of teen girls have STIs by 2 years of first sex
December 5, 2009Within 2 years of having sex for the first time, half of teenage girls may be at least one of three common sexually transmitted infections (STIs), according to results of a study published today. Often, those girls are infected by the age of 15.
Researchers followed 386 urban adolescent girls aged 14 to 17 for up to 8 years. Within 2 years of becoming sexually active, half of the girls were infected with at least one of three common sexually transmitted organisms: Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis -- the organisms that cause chlamydia, gonorrhea and trichomoniasis, respectively.
The researchers found that a quarter of the women had acquired their first STI by age 15, most often Chlamydia.
"Repeated infections were very common," study investigator Dr. Wanzhu Tu, of Indiana University School of Medicine in Indianapolis told Reuters Health by email. "Within 4 to 6 months (depending on the organism) after treatment of the previous infection, a quarter of the women were re-infected with the same organism."
Tu said young women are at risk of STIs as soon as they become sexually active, but recommendations are lacking about when it is appropriate to begin screening.
"These young women are vulnerable to STIs, but because of their younger age, they may not be perceived by health care providers as having STI risk, and thus are not screened in a timely manner."
The current findings, Tu said, highlight the importance of early STI screening and treatment. "For urban adolescent women, STI screening (especially for chlamydia) should begin within 1 year after first intercourse and infected individuals should be retested frequently, preferably every 3 to 4 months," the researcher said.
"To my knowledge, this study provides the first data on the timing of the initial STI and subsequent STIs following the onset of sexual activity in urban adolescent women," Tu added.
The study findings appear in the latest issue of Archives of Pediatrics and Adolescent Medicine, published by the American Medical Association.
A companion paper in the journal details a program that proved successful in curbing risky sexual behavior among 15- to 21-year-old African American adolescent girls and young women.
The participants, all of whom where visiting a sexual health clinic in Atlanta, took part in two group counseling sessions and received telephone support and vouchers to give to their partners to encourage them to get tested and treated for STIs.
This study is "exciting" for several reasons, Dr. Bonita Stanton from Wayne State University in Detroit wrote in a commentary. First, the program reduced first and recurrent chlamydia infections and led to higher rates of self-reported condom use, she points out.
Second, it got the teen girls cut back on douching, which has been linked to increased risk of STIs.
But perhaps "most intriguing," Stanton wrote, is that the young adolescent girls who participated in the program were able to convince their sexual partners to get tested for STIs.
Archive issues: (50)
Archive list: 1 2 3 4 5 6 7 [8] 9 10 11 12 13 14 15 16 17
November 23, 2009 | Genetic Variant Slows AIDS ProgressionScientists report that a genetic variation appears to play a major role in slowing disease progression in HIV-infected patients. In fact, those with the variation appear to take years longer to develop AIDS and die of complications of the disease. "We're honing in on factors that vary across individuals that make a person more or less susceptible to HIV, in terms of how rapidly someone develops the disease," said study ...
November 22, 2009 | FDA To Reduce the Misuse of MedicationsThe FDA wants to reduce the misuse of medications, saying that at least 50,000 hospitalizations a year could be prevented if physicians, pharmacists, patients and parents would be more careful. And the cost of these preventable injuries is estimated at about $4 billion annually by the Institute of Medicine. FDA commissioner Margaret A. Hamburg stated, "when I first started looking at this, I ...
November 21, 2009 | Diabetes Drug Byetta Linked to Kidney ProblemsThe FDA has received 78 reports of kidney problems related to Byetta, a drug by Amylin Pharmaceuticals and Eli-Lilly prescribed to treat type 2 diabetes. With the new findings, the drug's label will be updated to warn doctors and patients about this possible side effect. Byetta ...
Related articles:
Chronic bacterial prostatitis - treatment
Treatment requires prolonged courses (4-8 weeks) of antibiotics that penetrate the prostate well (?-lactams and nitrofurantoin are ineffective). These include quinolones (ciprofloxacin, levofloxacin), sulfas (Bactrim, Septra) and macrolides (erythromycin, clarithromycin). Persistent infections may be helped in 80% of patients by the use of alpha blockers (tamsulosin (Flomax), alfuzosin), or long term low dose antibiotic therapy. Recurrent infections may be caused by inefficient urination (benign prostatic hypertrophy, neurogenic bladder), prostatic stones ...Section: Prostatitis
Alprostadil
Alprostadil can be injected into the penis or inserted using a special applicator - usually just before sexual intercourse. Alprostadil has also become available in some countries as a topical cream (under the brand name Befar), and preliminary studies have shown a clinical efficacy of up to 83%. It has an onset of action of 10-15 minutes and its effects can last over 4 ...Section: Erectile Dysfunction
Symptoms
The symptoms of IC/PBS are often misdiagnosed as a "common" bladder infection (cystitis) or a UTI. However IC/PBS has not been shown to be caused by a bacterial infection, and the mis-prescribed treatment of antibiotics is ineffective. The symptoms of IC/PBS may also initially be attributed to prostatitis and ...Section: Interstitial cystitis